SEC Form 13F

BOONE CAPITAL MANAGEMENT LLC 13F Holdings

Inspect BOONE CAPITAL MANAGEMENT LLC's 2026-06-30 SEC 13F positions, public filing date, amendments and original receipt.

As of 2026-08-15T03:59:59.999Z

Report period
2026-06-30
Publicly available
2026-08-15
Reported value
$427,536,296
Positions
16

Disclosed positions

TELEFLEX INCORPORATEDTFXCOM$49,105,303387,388SHNone
MIRUM PHARMACEUTICALS INCMIRMCOM$48,659,092415,641SHNone
THE CIGNA GROUPCICOM$43,913,067159,290SHNone
IONIS PHARMACEUTICALS INCIONSCOM$41,228,976519,977SHNone
UNITEDHEALTH GROUP INCUNHCOM$36,860,97888,687SHNone
BIOMARIN PHARMACEUTICAL INCBMRNCOM$33,371,791583,219SHNone
GUARDIAN PHARMACY SVCS INCGRDNCL A$29,808,886711,939SHNone
VESTIS CORPORATIONVSTSCOM SHS$27,590,0331,900,140SHNone
BRIDGEBIO PHARMA INCBBIOCOM$25,302,346339,720SHNone
PENNANT GROUP INCPNTGCOM$19,059,475515,818SHNone
MONTE ROSA THERAPEUTICS INCGLUECOM$14,889,945615,287SHNone
KODIAK SCIENCES INCKODCOM$14,727,270378,010SHNone
TANGO THERAPEUTICS INCTNGXCOM$14,242,212455,605SHNone
KYMERA THERAPEUTICS INCKYMRCOM$12,977,548113,173SHNone
CULLINAN THERAPEUTICS INCCGEMCOM$12,827,889704,442SHNone
ADLAI NORTYE LTDANLSPONSORED ADS$2,971,485258,390SHNone

Largest 50 positions by reported value; the filing may contain more positions.

How amendments affect these holdings

This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 0 positions lack a resolved ticker and 0 positions are put or call entries.

A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.

Quarter end and public filing date

Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.